Here is a complete overview of Dolutegravir Tablet 50 mg with icons:
π Dolutegravir Tablet 50 mg
π§ͺ Nature / Drug Class
πΉ Antiretroviral Agent
πΉ Integrase Strand Transfer Inhibitor (INSTI)
πΉ Inhibits HIV enzyme integrase, preventing viral replication
π©Ί Purpose / Indications
β Used in the treatment of HIV-1 infection, including:
- 𧬠First-line therapy in adults and adolescents
- π Switch therapy from other ART regimens
- π‘οΈ Part of post-exposure prophylaxis (PEP)
βοΈ Advantages
βοΈ Potent viral suppression
βοΈ High genetic barrier to resistance
βοΈ Once-daily dosing in most cases
βοΈ Effective in naΓ―ve and treatment-experienced patients
βοΈ Fewer drug interactions than older agents
π¦ Common Packaging
π¦ Tablet: 50 mg
π Supplied in blister packs or bottles of 30 tablets
π§΄ Often part of fixed-dose combinations with other ARTs (e.g., with Lamivudine & Tenofovir)
β οΈ Patient Advice / Precautions
π Usually taken once daily
π½οΈ Can be taken with or without food
π€ May cause insomnia, headache, or mild dizziness
π« Avoid taking antacids, calcium, or iron within 2 hours (interferes with absorption)
π©βπΌ Considered safe in pregnancy, but requires medical guidance
𧬠Not for monotherapy β always use in combination with other ARTs
π§ Storage
π‘οΈ Store at room temperature
π« Protect from moisture and direct sunlight
π§ Keep out of reach of children